ACMT and AACT Position Statement: Preventing Occupational Fentanyl and Fentanyl Analog Exposure to Emergency Responders

J Med Toxicol. 2017 Dec;13(4):347-351. doi: 10.1007/s13181-017-0628-2. Epub 2017 Aug 25.

Authors

Michael J Moss¹, Brandon J Warrick², Lewis S Nelson³, Charles A McKay⁴, Pierre-André Dubé⁵, Sophie Gosselin⁶, Robert B Palmer⁷, Andrew I Stolbach⁸

Affiliations

¹ Oregon Poison Center, Portland, OR, USA.
² University of New Mexico, Albuquerque, NM, USA.
³ Rutgers New Jersey Medical School, Newark, NJ, USA.
⁴ University of Connecticut School of Medicine, Farmington, CT, USA.
⁵ Institut national de santé publique du Québec, Quebec City, Québec, Canada.
⁶ McGill University Health Center, Montreal, Québec, Canada.
⁷ University of Colorado School of Medicine, Aurora, CO, USA.
⁸ Johns Hopkins University, Baltimore, MD, USA. [email protected].

No abstract available

Publication types

Guideline

MeSH terms

Analgesics, Opioid / toxicity*
Emergency Responders*
Eye Protective Devices
Fentanyl / toxicity*
Gloves, Protective
Humans
Inhalation Exposure / adverse effects
Inhalation Exposure / prevention & control
Naloxone / administration & dosage
Naloxone / therapeutic use
Narcotic Antagonists / administration & dosage
Narcotic Antagonists / therapeutic use
National Academy of Sciences, U.S.
Occupational Exposure / prevention & control*
Opioid-Related Disorders / prevention & control*
Respiratory Protective Devices
United States

Substances

Analgesics, Opioid
Narcotic Antagonists
Naloxone
Fentanyl